| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0317167100027785 |
| P698 | PubMed publication ID | 3208214 |
| P2093 | author name string | Botez MI | |
| Attig E | |||
| Vézina JL | |||
| P2860 | cites work | Cerebellar degeneration following long-term phenytoin therapy | Q28330079 |
| Reversible chronic cerebellar ataxia after phenytoin intoxication: possible role of cerebellum in cognitive thought | Q34199212 | ||
| [Diphenylhydantoin, epilepsy, cerebellar atrophy--histological and electron microscope examinations (author's transl)] | Q36662703 | ||
| Frontal ventricular dimensions on normal computed tomography | Q39988032 | ||
| Diphenylhydantoin-induced cerebellar degeneration | Q42231962 | ||
| Cerebellar degeneration due to chronic phenytoin therapy | Q42271722 | ||
| Phenytoin-induced cerebellar degeneration | Q42273132 | ||
| Neuropathological changes in cerebellar biopsies of epileptic patients | Q48228299 | ||
| Cerebellar atrophy in phenytoin-treated mentally retarded epileptics | Q48268292 | ||
| The validity of criteria for the evaluation of cerebral atrophy by computed tomography | Q48453406 | ||
| Epileptic brain damage in adolescent baboons following seizures induced by allylgycine | Q48552590 | ||
| Cerebellar atrophy in epilepsy and headache: lack of relationship to phenytoin | Q48911998 | ||
| Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. | Q51229723 | ||
| Cerebellar degeneration with clinical manifestation in chronic epileptic patients. | Q51298300 | ||
| Cerebellar lesions after parenteral dilantin administration. | Q51322170 | ||
| A design for the prospective evaluation of the efficacy and toxicity of antiepileptic drugs in adults | Q71228489 | ||
| NEUROLOGICAL SEQUELAE FOLLOWING DILANTIN OVERDOSE IN A PATIENT AND IN EXPERIMENTAL ANIMALS | Q78514844 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 299-303 | |
| P577 | publication date | 1988-08-01 | |
| P1433 | published in | Canadian Journal of Neurological Sciences | Q5030246 |
| P1476 | title | Cerebellar atrophy in epileptic patients | |
| P478 | volume | 15 |
| Q36896821 | Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study |
| Q71987722 | Ataxia in institutionalized patients with epilepsy |
| Q33949043 | Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias. |
| Q36905603 | Cerebellar atrophy and prognosis after temporal lobe resection |
| Q34206424 | Cerebellar volume and long-term use of phenytoin |
| Q41514494 | Established antiepileptic drugs |
| Q48706711 | H. M.'s medial temporal lobe lesion: findings from magnetic resonance imaging |
| Q64063429 | Measuring the importance of vertices in the weighted human disease network |
| Q48491202 | Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma |
| Q41428291 | New drug therapy for acute seizure management |
| Q34447261 | Olivopontocerebellar atrophy and Friedreich's ataxia: neuropsychological consequences of bilateral versus unilateral cerebellar lesions. |
| Q74106991 | Patterns of cerebellar atrophy in patients with chronic epilepsy: a quantitative neuropathological study |
| Q48959053 | Prnp gene and cerebellum volume in patients with refractory mesial temporal lobe epilepsy |
| Q34765629 | The nature and extent of cerebellar atrophy in chronic temporal lobe epilepsy |
| Q28319037 | Thiamine status in inherited degenerative ataxias |
Search more.